{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T23:36:45Z","timestamp":1783985805223,"version":"3.55.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T00:00:00Z","timestamp":1691366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>It is known that patients reporting chronic pain often experience trauma or post-traumatic stress disorder (PTSD) and tend to be more difficult to treat. Attention deficit hyperactivity disorder (ADHD), a neurodevelopmental disorder, is frequently associated with chronic pain. Furthermore, patients diagnosed with ADHD are more likely to encounter trauma and develop PTSD because of their inattentive and impulsive tendencies. There are reports stating that atomoxetine (ATX), a selective noradrenaline reuptake inhibitor for ADHD, is effective in patients diagnosed with PTSD and ADHD. However, there have been no reports on cases of comorbid PTSD and ADHD with chronic pain, and ATX\u2019s potential in improving chronic pain coexisting PTSD. Furthermore, no reports have evaluated patient cerebral blood flow in conjunction with the course of treatment with ATX for chronic pain.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case report<\/jats:title><jats:p>In this study, we reported a case where ATX improved chronic pain with PTSD and improved cerebral blood flow. The patient was a 56-year-old woman exhibiting chronic pain with PTSD, resulting from 6\u2009years of severe domestic violence from her common-law husband. She had no history of ADHD diagnosis, but through aggressive screening, comorbid ADHD was diagnosed. When treated with ATX, there were significant improvements in her pain, quality of life, anxiety, depression, catastrophic thoughts, and cerebral blood flow. As a result, she could resume work after 11\u2009years.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The study showed that chronic pain with PTSD may be comorbid with ADHD. Moreover, we found that ATX can improve chronic pain with PTSD and cerebral blood flow. Aggressive screening of ADHD is important because once the diagnosis of comorbidity is confirmed, an ideal ADHD treatment can be selected. Therefore, based on the results of this study, ATX may be a candidate for treatment for cases of chronic pain with PTSD and ADHD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpsyt.2023.1221694","type":"journal-article","created":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T18:13:50Z","timestamp":1691432030000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Case report: Atomoxetine improves chronic pain with comorbid post-traumatic stress disorder and attention deficit hyperactivity disorder"],"prefix":"10.3389","volume":"14","author":[{"given":"Satoshi","family":"Kasahara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miwako","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taito","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko","family":"Matsudaira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimitsu","family":"Momose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-Ichi","family":"Niwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanji","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,7]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s11916-019-0828-3","article-title":"The interaction between chronic pain and PTSD","volume":"23","author":"Kind","year":"2019","journal-title":"Curr Pain Headache Rep"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/PSY.0000000000000789","article-title":"Attention-deficit\/hyperactivity disorder and chronic pain","volume":"82","author":"Kasahara","year":"2020","journal-title":"Psychosom Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1097\/PSY.0000000000000947","article-title":"Pain and attention-deficit\/hyperactivity disorder: the case of Margaret Mitchell","volume":"83","author":"Kasahara","year":"2021","journal-title":"Psychosom Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1038\/s41598-023-28931-3","article-title":"Diagnosis and treatment of intractable idiopathic orofacial pain with attention-deficit\/hyperactivity disorder","volume":"13","author":"Kasahara","year":"2023","journal-title":"Sci Rep"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e6422","DOI":"10.1002\/ccr3.6422","article-title":"Attention-deficit\/hyperactivity disorder and centralized pain: a review of the case of John F Kennedy","volume":"10","author":"Kasahara","year":"2022","journal-title":"Clin Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"E299","DOI":"10.36076\/ppj.2021\/24\/E299","article-title":"High attention-deficit\/hyperactivity disorder scale scores among patients with persistent chronic nonspecific low back pain","volume":"24","author":"Kasahara","year":"2021","journal-title":"Pain Phys"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"926946","DOI":"10.3389\/fpain.2022.926946","article-title":"Case report: treatment of persistent atypical odontalgia with attention deficit hyperactivity disorder and autism spectrum disorder with risperidone and atomoxetine","volume":"3","author":"Kasahara","year":"2022","journal-title":"Front Pain Res"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1091399","DOI":"10.3389\/fpsyt.2023.1091399","article-title":"Case report: methylphenidate improved chronic pain in an adult patient with attention deficit hyperactivity disorder","volume":"14","author":"Zain","year":"2023","journal-title":"Front Psych"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.4088\/JCP.14r09479","article-title":"Examining the association between posttraumatic stress disorder and attention-deficit\/hyperactivity disorder: a systematic review and meta-analysis","volume":"77","author":"Spencer","year":"2016","journal-title":"J Clin Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/da.23248","article-title":"Atomoxetine in comorbid ADHD\/PTSD: a randomized, placebo controlled, pilot, and feasibility study","volume":"39","author":"Wang","year":"2022","journal-title":"Depress Anxiety"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3934\/Neuroscience.2021003","article-title":"The extent of the neurocognitive impairment in elderly survivors of war suffering from PTSD: meta-analysis and literature review","volume":"8","author":"Rehman","year":"2021","journal-title":"AIMS Neurosci"},{"key":"ref12","volume-title":"The body keeps the score: mind, brain and body in the transformation of trauma","author":"van der Kolk","year":"2014"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41588-022-01057-4","article-title":"Genetic architecture of 11 major psychiatric disorders at biobehavioral, functional genomic and molecular genetic levels of analysis","volume":"54","author":"Grotzinger","year":"2022","journal-title":"Nat Genet"},{"key":"ref14","first-page":"19","article-title":"Self-report scales and procedures for assessing pain in adults","volume-title":"Handbook of pain assessment","author":"Jensen","year":"2011"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ejpain.2003.09.004","article-title":"Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale","volume":"8","author":"Salaffi","year":"2004","journal-title":"Eur J Pain"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","article-title":"Modeling valuations for EuroQol health states","volume":"35","author":"Dolan","year":"1997","journal-title":"Med Care"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.4081\/monaldi.2012.121","article-title":"EuroQol-5D (EQ-5D): an instrument for measuring quality of life","volume":"78","author":"Balestroni","year":"2012","journal-title":"Monaldi Arch Chest Dis"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e0229228","DOI":"10.1371\/journal.pone.0229228","article-title":"Clinically significant changes in pain along the pain intensity numerical rating scale in patients with chronic low back pain","volume":"15","author":"Suzuki","year":"2020","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/s0022-3999(01)00296-3","article-title":"The validity of the hospital anxiety and depression scale. An updated literature review","volume":"52","author":"Bjelland","year":"2002","journal-title":"J Psychosom Res"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1477-7525-6-46","article-title":"The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease","volume":"6","author":"Puhan","year":"2008","journal-title":"Health Qual Life Outcomes"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1037\/1040-3590.7.4.524","article-title":"The pain catastrophizing scale: development and validation","volume":"7","author":"Sullivan","year":"1995","journal-title":"Psychol Assess"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/00005053-200203000-00006","article-title":"Reliability and validity of the Japanese-language version of the impact of event scale-revised (IES-R-J): four studies of different traumatic events","volume":"190","author":"Asukai","year":"2002","journal-title":"J Nerv Ment Dis"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajp.2016.09.006","article-title":"The. Japanese version of the posttraumatic diagnostic scale: validity in participants with and without traumatic experiences","volume":"25","author":"Itoh","year":"2017","journal-title":"Asian J Psychiatr"},{"key":"ref25","first-page":"22","article-title":"The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"ref26","volume-title":"Section II: diagnostic criteria and codes. Diagnostic and statistical manual of mental disorders","year":"2013"},{"key":"ref27","volume-title":"Conners\u2019 adult ADHD rating scales (CAARS) [Technical manual]","author":"Conners","year":"1999"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"PCC.13r01600","DOI":"10.4088\/PCC.13r01600","article-title":"Underdiagnosis of attention-deficit\/hyperactivity disorder in adult patients: a review of the literature","volume":"16","author":"Ginsberg","year":"2014","journal-title":"Prim Care Companion CNS Disord"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1017\/S0140525X00013443","article-title":"Force and stiffness: further considerations","volume":"5","author":"Harvey","year":"1982","journal-title":"Behav Brain Sci"},{"key":"ref30","doi-asserted-by":"crossref","DOI":"10.1017\/9781108975292","volume-title":"Stahl\u2019s essential psychopharmacology: neuroscientific basis and practical applications","author":"Stahl","year":"2021"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00540-017-2343-1","article-title":"Attenuation of cortical activity triggering descending pain inhibition in chronic low back pain patients: a functional magnetic resonance imaging study","volume":"31","author":"Matsuo","year":"2017","journal-title":"J Anesth"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1037\/0033-295X.114.4.1047","article-title":"Stimulus-dependent dopamine release in attention-deficit\/hyperactivity disorder","volume":"114","author":"Sikstr\u00f6m","year":"2007","journal-title":"Psychol Rev"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/10582450802161960","article-title":"Use of atomoxetine in a patient with fibromyalgia syndrome and attention-deficit hyperactivity disorder","volume":"16","author":"Vorobeychik","year":"2008","journal-title":"J Musculoskelet Pain"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2165\/00003495-200464020-00005","article-title":"Atomoxetine: a review of its use in adults with attention deficit hyperactivity disorder","volume":"64","author":"Simpson","year":"2004","journal-title":"Drugs"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1586\/ern.10.198","article-title":"Functional neuroimaging studies of post-traumatic stress disorder","volume":"11","author":"Hughes","year":"2011","journal-title":"Expert Rev Neurother"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.2147\/NDT.S87359","article-title":"Atomoxetine treatment may decrease striatal dopaminergic transporter availability after 8 weeks: pilot SPECT report of three cases","volume":"11","author":"Akay","year":"2015","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3109\/00207454.2015.1074226","article-title":"Atomoxetine administration combined with intensive speech therapy for post-stroke aphasia: evaluation by a novel SPECT method","volume":"126","author":"Yamada","year":"2016","journal-title":"Int J Neurosci"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/WNF.0000000000000207","article-title":"Two cases of oral somatic delusions ameliorated with brain perfusion asymmetry: a case report","volume":"40","author":"Umezaki","year":"2017","journal-title":"Clin Neuropharmacol"},{"key":"ref39","volume-title":"Effective treatments for PTSD: practice guidelines from the international society for traumatic stress studies","author":"Forbes","year":"2020"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1089\/cap.2012.0119","article-title":"An open-label study of guanfacine extended release for traumatic stress related symptoms in children and adolescents","volume":"23","author":"Connor","year":"2013","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"e065997","DOI":"10.1136\/bmjopen-2022-065997","article-title":"Agile development of a digital exposure treatment for youth with chronic musculoskeletal pain: protocol of a user-centred design approach and examination of feasibility and preliminary efficacy","volume":"12","author":"Harrison","year":"2022","journal-title":"BMJ Open"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1221694\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T18:14:04Z","timestamp":1691432044000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1221694\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,7]]},"references-count":41,"alternative-id":["10.3389\/fpsyt.2023.1221694"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2023.1221694","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,7]]},"article-number":"1221694"}}